CA Stock MarketDetailed Quotes

InnoCan Pharma Corp (INNO)

Watchlist
  • 8.000
  • -0.100-1.23%
15min DelayMarket Closed Jan 16 12:35 ET
35.99MMarket Cap-6.92P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

InnoCan Pharma Corp (INNO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
-20.90%6.82M
-18.95%7.01M
15.19%7.8M
115.55%29.44M
10.38%5.4M
111.22%8.62M
176.96%8.64M
333.85%6.77M
433.69%13.66M
331.10%4.89M
Operating revenue
-20.90%6.82M
-18.95%7.01M
15.19%7.8M
115.55%29.44M
10.38%5.4M
111.22%8.62M
176.96%8.64M
333.85%6.77M
433.69%13.66M
331.10%4.89M
Cost of revenue
-25.33%631K
25.54%811K
-11.21%681K
93.57%3.25M
64.24%992K
101.67%845K
38.92%646K
303.68%767K
271.46%1.68M
1,676.47%604K
Gross profit
-20.41%6.19M
-22.54%6.2M
18.56%7.12M
118.63%26.19M
2.80%4.41M
112.31%7.78M
201.13%8M
338.03%6M
468.49%11.98M
289.55%4.29M
Operating expense
-0.24%7.41M
-22.32%5.8M
-8.14%6.63M
73.84%27.43M
2.80%5.33M
52.51%7.43M
141.43%7.47M
173.63%7.21M
88.47%15.78M
106.49%5.18M
Selling and administrative expenses
-0.79%6.99M
-20.13%5.62M
-5.05%6.45M
85.09%25.89M
6.97%5.01M
58.82%7.05M
148.32%7.04M
234.10%6.79M
104.25%13.99M
117.32%4.68M
-Selling and marketing expense
-17.05%5.06M
-18.16%4.87M
13.24%5.65M
101.85%21.13M
7.49%4.09M
88.52%6.1M
168.15%5.95M
313.16%4.99M
265.54%10.47M
276.56%3.81M
-General and administrative expense
102.93%1.94M
-30.91%751K
-55.84%794K
35.18%4.75M
4.70%913K
-20.81%955K
76.75%1.09M
118.20%1.8M
-11.72%3.52M
-23.64%872K
Research and development costs
10.08%415K
-58.59%176K
-57.55%180K
-13.75%1.55M
-35.91%323K
-12.53%377K
65.37%425K
-29.80%424K
17.69%1.8M
41.18%504K
Operating profit
-446.02%-1.22M
-25.70%396K
140.35%489K
67.21%-1.25M
-2.80%-919K
129.19%352K
222.25%533K
4.27%-1.21M
39.31%-3.8M
36.55%-894K
Net non-operating interest income (expenses)
800.00%7K
-233.33%-4K
40.00%-3K
-130.43%-7K
-126.67%-4K
66.67%-1K
50.00%3K
-155.56%-5K
21.05%23K
150.00%15K
Non-operating interest income
--7K
----
----
--0
--0
--0
0.00%3K
--0
9.52%23K
62.50%13K
Non-operating interest expense
----
--4K
-40.00%3K
--7K
300.00%4K
-66.67%1K
----
400.00%5K
--0
-200.00%-2K
Other net income (expenses)
-162.96%-221K
-155.73%-501K
-15,000.00%-453K
955.51%2.17M
211.78%926K
156.80%351K
2,265.79%899K
-110.34%-3K
-110.77%-254K
26.92%297K
Gain on sale of security
-162.96%-221K
-155.73%-501K
-15,000.00%-453K
955.51%2.17M
211.78%926K
156.80%351K
2,265.79%899K
-110.34%-3K
-110.77%-254K
26.92%297K
Income before tax
-303.99%-1.43M
-107.60%-109K
102.70%33K
122.78%919K
100.52%3K
138.42%702K
462.12%1.43M
0.65%-1.22M
-3.76%-4.03M
50.21%-582K
Income tax
-47.37%220K
-56.90%206K
11.97%262K
451.87%1.18M
-76.17%51K
418K
478K
234K
21,300.00%214K
21,300.00%214K
Earnings from equity interest net of tax
Net income
-681.69%-1.65M
-132.95%-315K
84.25%-229K
93.83%-262K
93.97%-48K
115.54%284K
341.41%956K
-18.40%-1.45M
-9.23%-4.25M
31.97%-796K
Net income continuous operations
-681.69%-1.65M
-132.95%-315K
84.25%-229K
93.83%-262K
93.97%-48K
115.54%284K
341.41%956K
-18.40%-1.45M
-9.23%-4.25M
31.97%-796K
Noncontrolling interests
-48.61%295K
-55.57%275K
12.78%353K
247.79%1.57M
-24.14%66K
187.00%574K
399.19%619K
645.24%313K
461.60%452K
135.14%87K
Net income attributable to the company
-571.38%-1.95M
-275.07%-590K
67.06%-582K
60.98%-1.83M
87.09%-114K
85.69%-290K
164.81%337K
-39.13%-1.77M
-24.87%-4.7M
26.84%-883K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-571.38%-1.95M
-275.07%-590K
67.06%-582K
60.98%-1.83M
87.09%-114K
85.69%-290K
164.81%337K
-39.13%-1.77M
-24.87%-4.7M
26.84%-883K
Diluted earnings per share
-447.69%-0.356
-300.00%-0.13
60.00%-0.13
50.00%-0.65
33.33%-0.26
85.71%-0.065
150.00%0.065
0.00%-0.325
-25.00%-1.3
-20.00%-0.39
Basic earnings per share
-447.69%-0.356
-300.00%-0.13
60.00%-0.13
50.00%-0.65
33.33%-0.26
85.71%-0.065
150.00%0.065
0.00%-0.325
-25.00%-1.3
-20.00%-0.39
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue -20.90%6.82M-18.95%7.01M15.19%7.8M115.55%29.44M10.38%5.4M111.22%8.62M176.96%8.64M333.85%6.77M433.69%13.66M331.10%4.89M
Operating revenue -20.90%6.82M-18.95%7.01M15.19%7.8M115.55%29.44M10.38%5.4M111.22%8.62M176.96%8.64M333.85%6.77M433.69%13.66M331.10%4.89M
Cost of revenue -25.33%631K25.54%811K-11.21%681K93.57%3.25M64.24%992K101.67%845K38.92%646K303.68%767K271.46%1.68M1,676.47%604K
Gross profit -20.41%6.19M-22.54%6.2M18.56%7.12M118.63%26.19M2.80%4.41M112.31%7.78M201.13%8M338.03%6M468.49%11.98M289.55%4.29M
Operating expense -0.24%7.41M-22.32%5.8M-8.14%6.63M73.84%27.43M2.80%5.33M52.51%7.43M141.43%7.47M173.63%7.21M88.47%15.78M106.49%5.18M
Selling and administrative expenses -0.79%6.99M-20.13%5.62M-5.05%6.45M85.09%25.89M6.97%5.01M58.82%7.05M148.32%7.04M234.10%6.79M104.25%13.99M117.32%4.68M
-Selling and marketing expense -17.05%5.06M-18.16%4.87M13.24%5.65M101.85%21.13M7.49%4.09M88.52%6.1M168.15%5.95M313.16%4.99M265.54%10.47M276.56%3.81M
-General and administrative expense 102.93%1.94M-30.91%751K-55.84%794K35.18%4.75M4.70%913K-20.81%955K76.75%1.09M118.20%1.8M-11.72%3.52M-23.64%872K
Research and development costs 10.08%415K-58.59%176K-57.55%180K-13.75%1.55M-35.91%323K-12.53%377K65.37%425K-29.80%424K17.69%1.8M41.18%504K
Operating profit -446.02%-1.22M-25.70%396K140.35%489K67.21%-1.25M-2.80%-919K129.19%352K222.25%533K4.27%-1.21M39.31%-3.8M36.55%-894K
Net non-operating interest income (expenses) 800.00%7K-233.33%-4K40.00%-3K-130.43%-7K-126.67%-4K66.67%-1K50.00%3K-155.56%-5K21.05%23K150.00%15K
Non-operating interest income --7K----------0--0--00.00%3K--09.52%23K62.50%13K
Non-operating interest expense ------4K-40.00%3K--7K300.00%4K-66.67%1K----400.00%5K--0-200.00%-2K
Other net income (expenses) -162.96%-221K-155.73%-501K-15,000.00%-453K955.51%2.17M211.78%926K156.80%351K2,265.79%899K-110.34%-3K-110.77%-254K26.92%297K
Gain on sale of security -162.96%-221K-155.73%-501K-15,000.00%-453K955.51%2.17M211.78%926K156.80%351K2,265.79%899K-110.34%-3K-110.77%-254K26.92%297K
Income before tax -303.99%-1.43M-107.60%-109K102.70%33K122.78%919K100.52%3K138.42%702K462.12%1.43M0.65%-1.22M-3.76%-4.03M50.21%-582K
Income tax -47.37%220K-56.90%206K11.97%262K451.87%1.18M-76.17%51K418K478K234K21,300.00%214K21,300.00%214K
Earnings from equity interest net of tax
Net income -681.69%-1.65M-132.95%-315K84.25%-229K93.83%-262K93.97%-48K115.54%284K341.41%956K-18.40%-1.45M-9.23%-4.25M31.97%-796K
Net income continuous operations -681.69%-1.65M-132.95%-315K84.25%-229K93.83%-262K93.97%-48K115.54%284K341.41%956K-18.40%-1.45M-9.23%-4.25M31.97%-796K
Noncontrolling interests -48.61%295K-55.57%275K12.78%353K247.79%1.57M-24.14%66K187.00%574K399.19%619K645.24%313K461.60%452K135.14%87K
Net income attributable to the company -571.38%-1.95M-275.07%-590K67.06%-582K60.98%-1.83M87.09%-114K85.69%-290K164.81%337K-39.13%-1.77M-24.87%-4.7M26.84%-883K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -571.38%-1.95M-275.07%-590K67.06%-582K60.98%-1.83M87.09%-114K85.69%-290K164.81%337K-39.13%-1.77M-24.87%-4.7M26.84%-883K
Diluted earnings per share -447.69%-0.356-300.00%-0.1360.00%-0.1350.00%-0.6533.33%-0.2685.71%-0.065150.00%0.0650.00%-0.325-25.00%-1.3-20.00%-0.39
Basic earnings per share -447.69%-0.356-300.00%-0.1360.00%-0.1350.00%-0.6533.33%-0.2685.71%-0.065150.00%0.0650.00%-0.325-25.00%-1.3-20.00%-0.39
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.85%
Sample Name
Sample Code
 +16.38%
Sample Name
Sample Code
 +13.45%
4
BIDU-SW
09888
+5.97%
5
JD HEALTH
06618
+5.25%
View More
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.11%
Sample Name
Sample Code
 +2.53%
Sample Name
Sample Code
 +2.08%
4
Tempus AI
TEM
+2.05%
5
Block
XYZ
+1.59%
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -